F. Edward Boas -- Home page

2022-06-12: SIR 2022. Boas FE. "Transarterial Chemoembolization of Lung Metastases."

2022-03-26: SIO 2022. Boas FE. "Transarterial Chemoembolization of Lung Metastases."

2020-03-31: SIR 2020, Seattle. Nurili F, Bendet A, Monette S, Michel A, Basturk O, Askan G, Cheleuitte-Nieves C, Yarmohammadi H, Schachtschneider KM, Gaba RC, Schook LB, Solomon SB, Boas FE. "Transarterial embolization of liver cancer in a transgenic pig model." [ Abstract | Video ]

2020-03-31: SIR 2020, Seattle. Boas FE, Nurili F, Bendet A, Cheleuitte-Nieves C, Basturk O, Askan G, Monette S, Michel A, Schook LB, Solomon SB, Kelsen DP, Scherz A, Yarmohammadi H. "Development of a transgenic pig model of pancreatic cancer." [ Abstract | Video ]

2019-03-25: SIR 2019, Austin, TX. Boas F, Nurili F, Erinjeri J, Schook L, Solomon S, Yarmohammadi H. "Local immunotherapy: Intra-arterial liver tumor vaccination in a pig model of metastatic pancreatic cancer."

2019-03-27: SIR 2019, Austin, TX. Zhang Y, Deipolyi A, Yarmohammadi H, Ziv E, Sofocleous C, Boas F. "Outcomes after radioembolization involving the phrenic artery."

2018-06-09: WCIO, Boston, MA. Yoon H, Mandel JE, Zener R, Yarmohammadi H, Solomon SB, Sofocleous CT, Boas FE. "Outcomes after locoregional therapy of pancreatic adenocarcinoma liver metastases."

2018-03-21: SIR 2018, Los Angeles, CA. Boas FE, Brown KT, Ziv E, Yarmohammadi H, Erinjeri JP, Sofocleous CT, Harding JJ, Solomon SB. "Aspirin is associated with lower bilirubin after embolization of hepatocellular carcinoma." [ Slides | More info ]

2018-03-21: SIR 2018, Los Angeles, CA. Zener R, Yoon H, Ziv E, Covey A, Brown KT, Sofocleous CT, Thornton RH, Boas FE. "Outcomes after transarterial embolization versus radioembolization of neuroendocrine tumor liver metastases."

2017-06-10: WCIO 2017, Boston, MA. Boas F, Ziv E, Yarmohammadi H, Brown K, Erinjeri J, Sofocleous C, Harding J, Solomon S. "Adjuvant medications that improve survival after locoregional therapy." More info »

2017-03-07: SIR 2017, Washington, DC. Boas F, Gonzalez Aguirre A, Srimathveeravalli G, Rund L, Schwind R, Schook L, Erinjeri J, Solomon S, Yarmohammadi H. "Induction of pancreatic cancer in a porcine model: Initial results."

2017-03-05: SIR 2017, Washington, DC. Yarmohammadi H, Gonzalez-Aguirre AJ, Schook L, Ziv E, Erinjeri JP, Brown KT, Srimathveeravalli G, O'Reilly EM, Allen PJ, Solomon SB, Boas FE. "Treatment of pancreatic cancer by intra-arterial injection of an emulsion of Lipiodol and Bumetanide (an anti-glycolytic drug) in a porcine model: Initial results."

2017-03-07: SIR 2017, Washington, DC. Boas F, Ziv E, Yarmohammadi H, Brown K, Erinjeri J, Sofocleous C, Harding J, Solomon S. "Home medications that improve survival after locoregional therapy." More info »

2017-03-05: SIR 2017, Washington, DC. Borgheresi A, Gonzalez-Aguirre A, Brown KT, Getrajdman GI, Erinjeri JP, Covey A, Yarmohammadi H, Ziv E, Sofocleous C, Boas FE. "Does enhancement or perfusion predict outcomes after embolization of hepatocellular carcinoma."

2017-03-01: ECR 2017, Vienna. "Precision medicine and image guided interventions" in "Oncologic imaging in the age of precision medicine."

2016-06-10: WCIO, Boston, MA. Fine GC, Boas FE, Durack JC, Covey A, Getrajdman GI, Erinjeri JP, Brody LA, Maybody M, Muallem N, Brown KT. "Outcomes after portal vein stenting in cancer patients."

2016-04-04: SIR 2016, Vancouver. Basic embolization I (patient selection and triage) case-based workshop.

2016-04-03: SIR 2016, Vancouver. Boas FE, Srimathveeravalli G, Kaye E, Durack JC, Erinjeri JP, Ziv E, Maybody M, Yarmohammadi H, Solomon SB. "Development of a searchable database of cryoablation simulations, for use in treatment planning."

2015-12-01: RSNA 2015, Chicago. Boas FE, Brody LA, Erinjeri JP, Yarmohammadi H, Shady W, Kishore S, Sofocleous CT. "Quantitative Enhancement Measurements on Pre-procedure Triphasic CT Can Predict Response to Radioembolization of Colorectal Liver Metastases."

2014-03-23: SIR 2014, San Diego. Boas FE, Kelly P, and Shlansky-Goldberg R. "Targeted transgastric drainage of persistent pancreaticocutaneous fistulas." More info »

2013-04-15: ARRS 2013, Washington, DC. "Hepatic Artery and Portal Vein Blood Volumes in Hypervascular Liver Lesions: Estimation From Triphasic CT Scans." More info »

2012-11-26: RSNA 2012, Chicago. "Optimized CT Metal Artifact Reduction Using the Metal Deletion Technique (MDT)." [ Abstract | Slides | More info ]

2012-04-03: Radiology grand rounds, Stanford. "CT metal artifact reduction and other image post-processing applications." [ Video | Slides (PDF) | More info ]

2011-06-13: International symposium on multidetector row CT, San Francisco. "Iterative techniques for metal artifact reduction." More info »

2011-05-03: ARRS annual meeting, Chicago. "Does separating the resistive index into pre- and postglomerular resistance and vascular compliance improve the diagnostic accuracy of renal transplant doppler ultrasound?"

2010-11-29: RSNA, Chicago. "Evaluation of the metal deletion technique (MDT): A new method for reducing metal streak artifacts in computed tomography scans." More info »


Transcatheter aortic valve replacement planning tool	Virtual angiography	Optimal HCC surveillance schedule	Transgastric pancreatic duct drain

Selected recent publications	Pedersoli F, Mohammad IS, Patel AK, Kessler J, Chao C, Liu B, Lall C, Guerra C, Park JJ, Boas FE. (2024) "Bioinspired intratumoral infusion port catheter improves local drug delivery in the liver." Scientific reports. 14: 27782. Lee J, Boas FE, Duran-Struuck R, Gaba RC, Schachtschneider KM, Comin-Anduix B, Galic Z, Haile S, Bassir A, Chiang J. (2024) "Pigs as clinically relevant models for synergizing interventional oncology and immunotherapy." Journal of Vascular and Interventional Radiology. 35(6):809-17. Boas FE, Salgia R, Waddington T, Massarelli E, Park JJ, Kessler J, Frankel P, Alexander ES, Solomon SB. (2023) "Phase II trial of lung chemoembolization." Journal of Vascular and Interventional Radiology. 34: 2090-2092. Boas FE, Maxwell AWP. (2023) "Beyond mean tumor dose: The importance of particle density in radioembolization." Journal of Vascular and Interventional Radiology. 34: 1235-6. Ghosn M, Elsakka AS, Petre EN, Cheleuitte-Nieves C, Tammela T, Monette S, Ziv E, Schachtschneider KM, Srimathveeravalli G, Yarmohammadi H, Boas FE, Solomon SB. (2023) "Induction and Preliminary Characterization of Neoplastic Pulmonary Nodules in a Transgenic Pig Model." Lung Cancer. 178: 157-65. Maxwell AWP, Mendoza HG, Sellitti MJ, Camacho JC, Deipolyi AR, Ziv E, Sofocleous CT, Yarmohammadi H, Maybody M, Humm JL, Schwartz J, Juluru K, Dunphy MP, Boas FE. (2022) "Optimizing ⁹⁰Y particle density improves outcomes after radioembolization." Cardiovascular and Interventional Radiology. 45: 958-69. [ Author's version ] Boas FE, Kemeny NE, Sofocleous CT, Yeh R, Thompson VR, Hsu M, Moskowitz CS, Ziv E, Yarmohammadi H, Bendet A, Solomon SB. (2021) "Bronchial or Pulmonary Artery Chemoembolization for Unresectable and Unablatable Lung Metastases: A Phase I Clinical Trial." Radiology. 301(2): 474-84. Nurili F, Monette S, Michel AO, Bendet A, Basturk O, Askan G, Cheleuitte-Nieves C, Yarmohammadi H, Maxwell AWP, Ziv E, Schachtschneider KM, Gaba RC, Schook LB, Solomon SB, Boas FE. (2021) "Transarterial embolization of liver cancer in a transgenic pig model." Journal of Vascular and Interventional Radiology. 32(4): 510-7. Boas FE, Nurili F, Bendet A, Cheleuitte-Nieves C, Basturk O, Askan G, Michel AO, Monette S, Ziv E, Sofocleous CT, Maxwell AWP, Schook LB, Solomon SB, Kelsen DP, Scherz A, Yarmohammadi H. (2020) "Induction and characterization of pancreatic cancer in a transgenic pig model." PLOS ONE. 15(9): e0239391. Boas FE, Brown KT, Ziv E, Yarmohammadi H, Sofocleous CT, Erinjeri JP, Harding JJ, Solomon SB. (2019) "Aspirin is associated with improved liver function after embolization of hepatocellular carcinoma." AJR. 213:689-95. More info » Zener R, Yoon H, Ziv E, Covey A, Brown KT, Sofocleous CT, Thornton RH, Boas FE. (2019) "Outcomes after transarterial embolization of neuroendocrine tumor liver metastases using spherical particles of different sizes." Cardiovascular and Interventional Radiology. 42: 569-76. Maybody M, Muallem N, Brown KT, Moskowitz CS, Hsu M, Zenobi CL, Jihad M, Getrajdman GI, Sofocleous CT, Erinjeri JP, Covey AM, Brody LA, Yarmohammadi H, Deipolyi AR, Bryce Y, Alago W, Siegelbaum RH, Durack JC, Gonzalez-Aguirre AJ, Ziv E, Boas FE, Solomon SB. (2019) "Autologous blood patch injection versus hydrogel plug in CT-guided lung biopsy: A prospective randomized trial." Radiology. 290: 547-54. Borgheresi A, Gonzalez-Aguirre A, Brown KT, Getrajdman GI, Erinjeri JP, Covey A, Yarmohammadi H, Ziv E, Sofocleous CT, Boas FE. (2018) "Does enhancement or perfusion on pre-procedure CT predict outcomes after embolization of hepatocellular carcinoma?" Academic Radiology. 25(12): 1588-94. More info » Sofocleous CT, Boas FE. (2018) "Radiation segmentectomy for hepatocellular carcinoma: Ready for prime time?" Radiology. 287: 1059-60. Boas FE, Bodei L, Sofocleous CT. (2017) "Radioembolization of colorectal liver metastases: Indications, technique, and outcomes." J Nucl Med. 58: 104S-111S. Boas FE, Ziv E, Yarmohammadi H, Brown KT, Erinjeri JP, Sofocleous CT, Harding JJ, Solomon SB. (2017) "Adjuvant medications that improve survival after locoregional therapy." Journal of Vascular and Interventional Radiology. 28(7): 971-977. More info » Boas FE, Srimathveeravalli G, Kaye EA, Durack JC, Erinjeri JP, Ziv E, Maybody M, Yarmohammadi H, Solomon SB. (2017) "Development of a searchable database of cryoablation simulations, for use in treatment planning." Cardiovascular and Interventional Radiology. 40(5): 761-8. More info » Boas FE, Brody LA, Erinjeri JP, Yarmohammadi H, Shady W, Kishore S, Sofocleous CT. (2016) "Quantitative enhancement measurements on preprocedure triphasic CT can predict response to radioembolization of colorectal liver metastases." AJR. 207: 671-5. More info » Ziv E, Erinjeri JP, Yarmohammadi H, Boas FE, Petre EB, Gao S, Shady W, Sofocleous CT, Jones DR, Rudin CM, Solomon SB. (2016) "Lung adenocarcinoma: Predictive value of KRAS mutation status in assessing local recurrence in patients undergoing image-guided ablation." Radiology. 282(1): 251-8. Boas FE, Kadivar F, Kelly PD, Drebin JA, Vollmer CM, Shlansky-Goldberg RD. (2015) "Targeted transgastric drainage of isolated pancreatic duct segments to cure persistent pancreaticocutaneous fistulas from pancreatitis." J Vasc Interv Radiol. 26(2): 247-51. More info » Boas FE, Do B, Louie JD, Kothary N, Hwang GL, Kuo WT, Hovsepian DM, Kantrowitz M, Sze DY. (2015) "Optimal imaging surveillance schedules after liver-directed therapy for hepatocellular carcinoma." J Vasc Interv Radiol. 26(1): 69-73. More info » Boas FE, Kamaya A, Do B, Desser TS, Beaulieu CF, Vasanawala SS, Hwang GL, Sze DY. (2015) "Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans." Journal of Digital Imaging. 28: 213-23. More info » Boas FE. (2012) "Iterative reduction of artifacts in computed tomography images using forward projection and an edge-preserving blur filter." U.S. Patent 8233586. Boas FE and Fleischmann D. (2012) "Computed tomography artifacts: Causes and reduction techniques." Imaging in Medicine. 4(2): 229-40. More info » Boas FE and Fleischmann D. (2011) "Evaluation of two iterative techniques for reducing metal artifacts in computed tomography." Radiology. 259(3): 894-902. More info » Fleischmann D and Boas FE. (2011) "Computed tomography: Old ideas and new technology." European Radiology. 21: 510-17. More publications Boas FE, Harbury PB. (2008) "Design of protein-ligand binding based on the molecular-mechanics energy model." Journal of Molecular Biology. 380: 415-24. More info » Boas FE and Harbury PB. (2007) "Potential energy functions for protein design." Current Opinion in Structural Biology. 17: 199-204. More info » Boas FE. (2000) "Linkage to Gaucher mutations in the Ashkenazi population: Effect of drift on decay of linkage disequilibrium and evidence for heterozygote selection." Blood Cells, Molecules, and Diseases. 26(4): 348-59. More info » Boas FE, Forman L, and Beutler E. (1998) "Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia." Proc. Natl. Acad. Sci., USA. 95: 3077-3081. More info » Ahn CS, Boas E, and Rahn B. (1997) "The geometry and the game theory of chases." The UMAP Journal. 18.3: 225-242. More info » Complete list of publications
Patent applications	Boas FE, Pedersoli F. (2024) "Intratumoral infusion catheter." US Patent Appl. Assignee: COH. [ Licensing information ] Boas FE. (2024) "Systems and methods related to dosimetry for radioembolization, chemoembolization, and drug eluting embolization procedures." US Patent Appl. 18/607,972. [ Licensing information ] Boas FE, Erinjeri J. (2019) "Intra-arterial injection of vaccine adjuvants into tumors for treatment of metastatic cancer." US Prov. Appl. No. 62/817,116. [ Licensing information ] Boas FE. (2018) "Improved intra-arterial tumor targeting using an omniphobic oil." US Prov. Appl. No. 62/754,139. [ Licensing information ] Boas FE. (2012) "Iterative reduction of artifacts in computed tomography images using forward projection and an edge-preserving blur filter." U.S. Patent 8233586. [ Licensing information ]
Selected book chapters	Boas FE. (2024) "Embolization for lung tumors." In Fong Y, Covey A, Ahmed M, Kessler J, Iannitti D, and Dupuy D (Eds.), Interventional Oncology: Multidisciplinary Approach to Image-Guided Cancer Therapy, 2nd ed. Springer Nature. Boas FE and Solomon SB. (2022) "Postoperative complications requiring intervention: Diagnosis and management." In WR Jarnagin (Ed.), Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas, 7th ed. New York, NY: Elsevier. Boas FE and Sofocleous CT. (2020) "Embolotherapy for the Management of Liver Malignancies Other Than Hepatocellular Carcinoma." In Mauro MA, Murphy KP, Thomson KR, Venbrux AC, and Morgan RA (Eds.), Image-Guided Interventions, 3rd edition, Expert Radiology Series. Solomon SB, Griffin JF, Weiss MJ, Boas FE. (2016). "Postoperative complications requiring intervention: Diagnosis and management." In WR Jarnagin (Ed.), Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas, 6th ed. New York, NY: Elsevier. Boas FE, Shlansky-Goldberg RD. (2015). "Role of interventional radiology in managing bile duct injuries." In Dixon E, Vollmer CM, May GR (Eds.), Management of Benign Biliary Stenosis and Injury: A Comprehensive Guide. New York, NY: Springer.
Press	Aspirin improves liver function after embolization of hepatocellular carcinoma. EurekAlert, AAAS, 2019-07-31. Memorial Sloan Kettering develops new tool for planning cryoablation procedures. Medgadget, 2017-01-13. A New Planning Tool for Cryoablation: An Interview With Franz Edward Boas, MD. Interventional Oncology 360°, 2016-05-17. [ Video \| Transcript ]
Selected talks / abstracts	2024-01-31: SIO 2024. Chemoembolization of lung cancer and lung metastases. 2022-06-14: SIR 2022. Youssef EW, Ghosn M, El Hawari M, Fine GC, Maybody M, Yarmohammadi H, Brown KT, Boas FE. "Portal vein stent placement for malignant portal vein occlusion." [ Paper ] 2022-06-12: SIR 2022. Maxwell AWP, Mendoza HG, Sellitti MJ, Camacho JC, Deipolyi AR, Ziv E, Sofocleous CT, Yarmohammadi H, Maybody M, Humm JL, Schwartz J, Juluru K, Dunphy MP, Boas FE. "Optimizing ⁹⁰Y particle density improves outcomes after radioembolization." 2022-06-12: SIR 2022. Boas FE. "Transarterial Chemoembolization of Lung Metastases." 2022-03-26: SIO 2022. Boas FE. "Transarterial Chemoembolization of Lung Metastases." 2021-06-04: ASCO 2021. Boas FE, Kemeny NE, Sofocleous CT, Yeh R, Thompson VR, Hsu M, Moskowitz CS, Ziv E, Yarmohammadi H, Bendet A, Solomon SB. "Phase I Study of Transarterial Chemoembolization of Lung Metastases." 2021-03-26: SIR 2021. Yarmohammadi H, Elsakka AS, Nurili F, Maxwell AWP, Ridouani F, Ziv E, O'Reilly EM, Cheleuitte-Nieves C, Schook LB, Solomon SB, Boas FE. "Treatment of pancreatic cancer by intra-arterial injection of an emulsion of Lipiodol and bumetanide (an anti-glycolytic drug) in a transgenic mutated pig model (Oncopig)." 2021-02-28: APSCVIR 2021. Boas FE. "New intra-arterial therapies for extrahepatic disease." 2020-11-30: RSNA 2020. Boas FE. "Special Interest Session: The Academy Imaging Shark Tank." 2020-03-29: SIR 2020, Seattle. Boas FE. "New intra-arterial therapies for pancreatic and lung cancer." 2020-03-31: SIR 2020, Seattle. Nurili F, Bendet A, Monette S, Michel A, Basturk O, Askan G, Cheleuitte-Nieves C, Yarmohammadi H, Schachtschneider KM, Gaba RC, Schook LB, Solomon SB, Boas FE. "Transarterial embolization of liver cancer in a transgenic pig model." [ Abstract \| Video ] 2020-03-31: SIR 2020, Seattle. Boas FE, Nurili F, Bendet A, Cheleuitte-Nieves C, Basturk O, Askan G, Monette S, Michel A, Schook LB, Solomon SB, Kelsen DP, Scherz A, Yarmohammadi H. "Development of a transgenic pig model of pancreatic cancer." [ Abstract \| Video ] More talks 2019-03-25: SIR 2019, Austin, TX. Boas F, Nurili F, Erinjeri J, Schook L, Solomon S, Yarmohammadi H. "Local immunotherapy: Intra-arterial liver tumor vaccination in a pig model of metastatic pancreatic cancer." 2019-03-27: SIR 2019, Austin, TX. Zhang Y, Deipolyi A, Yarmohammadi H, Ziv E, Sofocleous C, Boas F. "Outcomes after radioembolization involving the phrenic artery." 2018-06-09: WCIO, Boston, MA. Yoon H, Mandel JE, Zener R, Yarmohammadi H, Solomon SB, Sofocleous CT, Boas FE. "Outcomes after locoregional therapy of pancreatic adenocarcinoma liver metastases." 2018-03-21: SIR 2018, Los Angeles, CA. Boas FE, Brown KT, Ziv E, Yarmohammadi H, Erinjeri JP, Sofocleous CT, Harding JJ, Solomon SB. "Aspirin is associated with lower bilirubin after embolization of hepatocellular carcinoma." [ Slides \| More info ] 2018-03-21: SIR 2018, Los Angeles, CA. Zener R, Yoon H, Ziv E, Covey A, Brown KT, Sofocleous CT, Thornton RH, Boas FE. "Outcomes after transarterial embolization versus radioembolization of neuroendocrine tumor liver metastases." 2017-06-10: WCIO 2017, Boston, MA. Boas F, Ziv E, Yarmohammadi H, Brown K, Erinjeri J, Sofocleous C, Harding J, Solomon S. "Adjuvant medications that improve survival after locoregional therapy." More info » 2017-03-07: SIR 2017, Washington, DC. Boas F, Gonzalez Aguirre A, Srimathveeravalli G, Rund L, Schwind R, Schook L, Erinjeri J, Solomon S, Yarmohammadi H. "Induction of pancreatic cancer in a porcine model: Initial results." 2017-03-05: SIR 2017, Washington, DC. Yarmohammadi H, Gonzalez-Aguirre AJ, Schook L, Ziv E, Erinjeri JP, Brown KT, Srimathveeravalli G, O'Reilly EM, Allen PJ, Solomon SB, Boas FE. "Treatment of pancreatic cancer by intra-arterial injection of an emulsion of Lipiodol and Bumetanide (an anti-glycolytic drug) in a porcine model: Initial results." 2017-03-07: SIR 2017, Washington, DC. Boas F, Ziv E, Yarmohammadi H, Brown K, Erinjeri J, Sofocleous C, Harding J, Solomon S. "Home medications that improve survival after locoregional therapy." More info » 2017-03-05: SIR 2017, Washington, DC. Borgheresi A, Gonzalez-Aguirre A, Brown KT, Getrajdman GI, Erinjeri JP, Covey A, Yarmohammadi H, Ziv E, Sofocleous C, Boas FE. "Does enhancement or perfusion predict outcomes after embolization of hepatocellular carcinoma." 2017-03-01: ECR 2017, Vienna. "Precision medicine and image guided interventions" in "Oncologic imaging in the age of precision medicine." 2016-06-10: WCIO, Boston, MA. Fine GC, Boas FE, Durack JC, Covey A, Getrajdman GI, Erinjeri JP, Brody LA, Maybody M, Muallem N, Brown KT. "Outcomes after portal vein stenting in cancer patients." 2016-04-04: SIR 2016, Vancouver. Basic embolization I (patient selection and triage) case-based workshop. 2016-04-03: SIR 2016, Vancouver. Boas FE, Srimathveeravalli G, Kaye E, Durack JC, Erinjeri JP, Ziv E, Maybody M, Yarmohammadi H, Solomon SB. "Development of a searchable database of cryoablation simulations, for use in treatment planning." 2015-12-01: RSNA 2015, Chicago. Boas FE, Brody LA, Erinjeri JP, Yarmohammadi H, Shady W, Kishore S, Sofocleous CT. "Quantitative Enhancement Measurements on Pre-procedure Triphasic CT Can Predict Response to Radioembolization of Colorectal Liver Metastases." 2014-03-23: SIR 2014, San Diego. Boas FE, Kelly P, and Shlansky-Goldberg R. "Targeted transgastric drainage of persistent pancreaticocutaneous fistulas." More info » 2013-04-15: ARRS 2013, Washington, DC. "Hepatic Artery and Portal Vein Blood Volumes in Hypervascular Liver Lesions: Estimation From Triphasic CT Scans." More info » 2012-11-26: RSNA 2012, Chicago. "Optimized CT Metal Artifact Reduction Using the Metal Deletion Technique (MDT)." [ Abstract \| Slides \| More info ] 2012-04-03: Radiology grand rounds, Stanford. "CT metal artifact reduction and other image post-processing applications." [ Video \| Slides (PDF) \| More info ] 2011-06-13: International symposium on multidetector row CT, San Francisco. "Iterative techniques for metal artifact reduction." More info » 2011-05-03: ARRS annual meeting, Chicago. "Does separating the resistive index into pre- and postglomerular resistance and vascular compliance improve the diagnostic accuracy of renal transplant doppler ultrasound?" 2010-11-29: RSNA, Chicago. "Evaluation of the metal deletion technique (MDT): A new method for reducing metal streak artifacts in computed tomography scans." More info »
Funding	PI, "Phase II trial of lung chemoembolization." Guerbet (investigator initiated). 2023-2025. Co-PI (with Lawrence Schook, Ron Gaba, Stephen Solomon, Karen Brown), "Genetically Inducible Porcine Model of Primary and Metastatic HCC in Comorbidity Host Environments for Interventional Radiology-Guided Detection and Treatment." Department of Defense, Congressionally Directed Medical Research Programs. 08/01/2016 - 07/31/2020. PI, "Phase I study of transarterial chemoembolization of lung metastases." Society of Interventional Oncology, Transarterial lipiodol chemoembolization research grant. 2019 - 2020. PI, "Phase I study of transarterial chemoembolization of lung metastases." Brockman Medical Research Foundation. 2019 - 2021. Aim co-leader, "Targeting pancreatic cancer." Thompson family foundation. 2017 - 2022.